arrow
V

Van K. Morris

university of texas system
H指数:9
被引数:604

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II Trial

结直肠癌腺癌可切除肝脏与不可切除肺部转移灶的肝切除术联合化疗或单纯化疗治疗(LUNA):一项随机Ⅱ期临床试验

2025-12-100
PRE
Can Patients With Recurrent or Primary Squamous Cell Carcinoma of the Anus in a Previously Irradiated Pelvis Receive Definitive Reirradiation?

复发性或原发性肛管鳞状细胞癌患者,在先前接受过盆腔照射的情况下,能否接受根治性再照射?

2025-12-010
OA
Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAFV600E metastatic colorectal cancer

Ⅰ/Ⅱ期临床试验:encorafenib、cetuximab和nivolumab在微卫星稳定型BRAFV600E转移性结直肠癌中的应用

2025-08-280
OAAI
A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies

一项avelumab联合ivuxolimab、utomilumab和放射治疗的I/II期临床试验,用于治疗晚期胃肠道恶性肿瘤患者

2025-03-010
PRE
Epigenome Reprogramming Through H3K27 and H3K4 Trimethylation as a Resistance Mechanism to DNA Methylation Inhibition in BRAFV600E-Mutated Colorectal Cancer
2024-09-130
PRE
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer
2023-06-0714
OAAI